This page in English

Jan Albert

Professor/överläkare

Besöksadress : Karolinska Universitetssjukhuset, Solna; Klinisk Mikrobiologi L2:02, 171 76 Stockholm
Postadress : Institutionen för mikrobiologi, tumör- och cellbiologi (MTC), C1, Jan Albert grupp, Klinisk Mikrobiologi L2:02, Karolinska Universitetssjukhuset, Solna 171 76 Stockholm
Leveransadress : Karolinska Universitetslaboratoriet, Solna; Klinisk mikrobiologi L2:02, 171 76 Stockholm

Publikationer

A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model
Nakagawa F, Van Sighem A, Thiebaut R, Smith C, Ratmann O, Cambiano V, et al
Epidemiology (Cambridge, Mass.) 2016;27(2):247-56

Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
Gaines H, Albert J, Axelsson M, Berglund T, Gisslén M, Sönnerborg A, et al
Infectious diseases (London, England) 2016;48(2):93-8

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
Hofstra Lm, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, et al
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016;62(5):655-63

Challenges with using primer IDs to improve accuracy of next generation sequencing
Brodin J, Hedskog C, Heddini A, Benard E, Neher Ra, Mild M, et al
PloS one 2015;10(3):e0119123-

Coexistence of two clades of enterovirus D68 in pediatric Swedish patients in the summer and fall of 2014
Dyrdak R, Rotzén-Östlund M, Samuelson A, Eriksson M, Albert J
Infectious diseases (London, England) 2015;47(10):734-8

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis
Rhee Sy, Blanco Jl, Jordan Mr, Taylor J, Lemey P, Varghese V, et al
PLoS medicine 2015;12(4):e1001810-

Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast Asia
Angelis K, Albert J, Mamais I, Magiorkinis G, Hatzakis A, Hamouda O, et al
The Journal of infectious diseases 2015;211(11):1735-44

Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy
Von Stockenstrom S, Odevall L, Lee E, Sinclair E, Bacchetti P, Killian M, et al
The Journal of infectious diseases 2015;212(4):596-607

Population genomics of intrapatient HIV-1 evolution
Zanini F, Brodin J, Thebo L, Lanz C, Bratt G, Albert J, et al
eLife 2015;4():-

Trends of HIV-1 incidence with credible intervals in Sweden 2002-09 reconstructed using a dynamic model of within-patient IgG growth
Romero-severson Eo, Lee Petrie C, Ionides E, Albert J, Leitner T
International journal of epidemiology 2015;44(3):998-1006

Delayed HIV diagnosis common in Sweden, 2003-2010
Widgren K, Skar H, Berglund T, Kling Am, Tegnell A, Albert J
Scandinavian journal of infectious diseases 2014;46(12):862-7

Evaluation of bio-rad geenius HIV-1 and -2 assay as a confirmatory assay for detection of HIV-1 and -2 antibodies
Hawthorne Hallen A, Samuelson A, Nordin M, Albert J, Bogdanovic G
Clinical and vaccine immunology : CVI 2014;21(8):1192-4

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe
Spread Programme, Frentz D, Van De Vijver Damc, Abecasis Ab, Albert J, Hamouda O, et al
BMC INFECTIOUS DISEASES 2014;:407-

Patterns of transmitted HIV drug resistance in Europe vary by risk group
Frentz D, Van De Vijver D, Abecasis A, Albert J, Hamouda O, Jørgensen L, et al
PloS one 2014;9(4):e94495-

Performance of the Simplexa™ Flu A/B & RSV Direct Kit on respiratory samples collected in saline solution
Svensson Mj, Lind I, Wirgart Bz, Östlund Mr, Albert J
Scandinavian journal of infectious diseases 2014;46(12):825-31

Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013
Navér L, Albert J, Böttiger Y, Carlander C, Flamholc L, Gisslén M, et al
Scandinavian journal of infectious diseases 2014;46(6):401-11

Risk of HIV transmission from patients on antiretroviral therapy: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
Albert J, Berglund T, Gisslén M, Gröön P, Sönnerborg A, Tegnell A, et al
Scandinavian journal of infectious diseases 2014;46(10):673-7

Temporal trends in the Swedish HIV-1 epidemic: increase in non-B subtypes and recombinant forms over three decades
Neogi U, Häggblom A, Santacatterina M, Bratt G, Gisslén M, Albert J, et al
PloS one 2014;9(6):e99390-

Timing and order of transmission events is not directly reflected in a pathogen phylogeny
Romero-severson E, Skar H, Bulla I, Albert J, Leitner T
Molecular biology and evolution 2014;31(9):2472-82

Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic
Pineda-peña Ac, Schrooten Y, Vinken L, Ferreira F, Li G, Trovão Ns, et al
PloS one 2014;9(7):e101738-

A Single Early Introduction of HIV-1 Subtype B into Central America Accounts for Most Current Cases
Murillo W, Veras N, Prosperi M, De Rivera Il, Paz-bailey G, Morales-miranda S, et al
JOURNAL OF VIROLOGY 2013;87(13):7463-70

High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch
Mild M, Gray Rr, Kvist A, Lemey P, Goodenow Mm, Fenyö Em, et al
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2013;19():369-77

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
Abecasis Ab, Wensing Amj, Paraskevis D, Vercauteren J, Theys K, De Vijver Damcv, et al
RETROVIROLOGY 2013;:7-

Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network
Pillay D, Albert J, Bertagnolio S, Boucher C, Brun-vezinet F, Clotet B, et al
ANTIVIRAL THERAPY 2013;18(6):831-6

Limited cross-border infections in patients newly diagnosed with HIV in Europe
Spread Programme, Frentz D, Wensing Amj, Albert J, Paraskevis D, Abecasis Ab, et al
RETROVIROLOGY 2013;:36-

Longitudinal ultradeep characterization of HIV type 1 R5 and X4 subpopulations in patients followed from primary infection to coreceptor switch
Hedskog C, Brodin J, Heddini A, Bratt G, Albert J, Mild M
AIDS research and human retroviruses 2013;29(9):1237-44

Oral Antiretroviral Drugs as Public Health Tools for HIV Prevention: Global Implications for Adherence, Drug Resistance, and the Success of HIV Treatment Programs
Gupta Rk, Wainberg Ma, Brun-vezinet F, Gatell Jm, Albert J, Sonnerborg A, et al
JOURNAL OF INFECTIOUS DISEASES 2013;:S101-6

PCR-induced transitions are the major source of error in cleaned ultra-deep pyrosequencing data
Brodin J, Mild M, Hedskog C, Sherwood E, Leitner T, Andersson B, et al
PloS one 2013;8(7):e70388-

Towards Estimation of HIV-1 Date of Infection: A Time-Continuous IgG-Model Shows That Seroconversion Does Not Occur at the Midpoint between Negative and Positive Tests
Skar H, Albert J, Leitner T
PLOS ONE 2013;8(4):e60906-

Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011
Bontell I, Häggblom A, Bratt G, Albert J, Sönnerborg A
PloS one 2013;8(3):e59337-

Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010
Karlsson A, Björkman P, Bratt G, Ekvall H, Gisslén M, Sönnerborg A, et al
PloS one 2012;7(3):e33484-

Phylogenetic analysis of the Latvian HIV-1 epidemic
Balode D, Skar H, Mild M, Kolupajeva T, Ferdats A, Rozentale B, et al
AIDS research and human retroviruses 2012;28(8):928-32

Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America
Murillo W, Lorenzana De Rivera I, Albert J, Guardado Me, Nieto Ai, Paz-bailey G
Journal of medical virology 2012;84(10):1514-21

Therapy failure resulting from superinfection by a drug-resistant HIV variant
Pingen M, Nouwen Jl, Dinant S, Albert J, Mild M, Brodin J, et al
ANTIVIRAL THERAPY 2012;17(8):1621-5

Transmission of the X4 Phenotype of HIV-1: Is There Evidence Against the "Random Transmission" Hypothesis?
Hedskog C, Mild M, Albert J
JOURNAL OF INFECTIOUS DISEASES 2012;205(2):163-5

Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients
Spread-programme, Theys K, Deforche K, Vercauteren J, Libin P, Van De Vijver Damc, et al
RETROVIROLOGY 2012;:81-

Daily Sampling of an HIV-1 Patient with Slowly Progressing Disease Displays Persistence of Multiple env Subpopulations Consistent with Neutrality
Skar H, Gutenkunst Rn, Ramsay Kw, Alaeus A, Albert J, Leitner T
PLOS ONE 2011;6(8):e21747-

Dynamics of Two Separate but Linked HIV-1 CRF01_AE Outbreaks among Injection Drug Users in Stockholm, Sweden, and Helsinki, Finland
Skar H, Axelsson M, Berggren I, Thalme A, Gyllensten K, Liitsola K, et al
JOURNAL OF VIROLOGY 2011;85(1):510-8

Estimates of HIV Transmitted Drug Resistance Can be Inflated Due to Natural Sequence Polymorphisms
Frentz D, Van De Vijver Damc, Boucher Cab, Albert J
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2011;58(5):e135-7

European guidelines on the clinical management of HIV-1 tropism testing
European Consensus Grp Clinical, Vandekerckhove Lpr, Wensing Amj, Kaiser R, Brun-vezinet F, Clotet B, et al
LANCET INFECTIOUS DISEASES 2011;11(5):394-407

Guidelines for HIV in court cases
Leitner T
NATURE 2011;473(7347):284-

Guidelines for HIV in court cases (vol 473, pg 284, 2011)
Leitner T
NATURE 2011;475(7354):37-37

HIV-1 evolution in relation to molecular epidemiology and antiretroviral resistance
Skar H, Hedskog C, Albert J
EVOLUTION OF INFECTIOUS AGENTS IN RELATION TO SEX 2011;:108-18

Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge
Borggren M, Repits J, Sterjovski J, Uchtenhagen H, Churchill Mj, Karlsson A, et al
PLOS ONE 2011;6(6):e20135-

Majority of CD4(+) T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule
Josefsson L, King Ms, Makitalo B, Brannstrom J, Shao W, Maldarelli F, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2011;108(27):11199-204

Performance of Ultra-Deep Pyrosequencing in Analysis of HIV-1 pol Gene Variation
Mild M, Hedskog C, Jernberg J, Albert J
PLOS ONE 2011;6(7):e22741-

Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2010
Naver L, Albert J, Belfrage E, Flamholc L, Gisslen M, Gyllensten K, et al
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES 2011;43(6-7):411-23

Reply to Redd et al
Nowroozalizadeh S, Mansson F, Da Silva Z, Repits J, Pereira C, Biague A, et al
JOURNAL OF INFECTIOUS DISEASES 2011;203(5):746-746

Science in court: the myth of HIV fingerprinting
Abecasis Ab, Geretti Am, Albert J, Power L, Weait M, Vandamme Am
LANCET INFECTIOUS DISEASES 2011;11(2):78-9

Short Communication: High Prevalence of Drug Resistance in HIV Type 1-Infected Children Born in Honduras and Belize 2001 to 2004
Parham L, De Rivera Il, Murillo W, Naver L, Largaespada N, Albert J, et al
AIDS RESEARCH AND HUMAN RETROVIRUSES 2011;27(10):1055-9

Towards a world free from HIV and AIDS?
Albert J, Chiodi F
JOURNAL OF INTERNAL MEDICINE 2011;270(6):502-8

Viral Linkage in HIV-1 Seroconverters and Their Partners in an HIV-1 Prevention Clinical Trial
Partners Prevention Hsv Hiv, Campbell Ms, Mullins Ji, Hughes Jp, Celum C, Wong Kg, et al
PLOS ONE 2011;6(3):e16986-

Analysis of HIV DNA molecules in paired peripheral blood and lymph node tissue samples from chronically infected patients
Josefsson L, Palmer S, Casazza J, Ambrozak D, Kearney M, Shao W, et al
ANTIVIRAL THERAPY 2010;:A41-A41

Analysis of HIV DNA molecules in paired peripheral blood and lymph node tissue samples from chronically infected patients
Josefsson L, Palmer S, Casazza J, Ambrozak D, Kearney M, Shao W, et al
ANTIVIRAL THERAPY 2010;15(4):A41-A41

Can the further clinical development of bevirimat be justified?
Wainberg Ma, Albert J
AIDS 2010;24(5):773-4

Dynamics of HIV-1 Quasispecies during Antiviral Treatment Dissected Using Ultra-Deep Pyrosequencing
Hedskog C, Mild M, Jernberg J, Sherwood E, Bratt G, Leitner T, et al
PLOS ONE 2010;5(7):e11345-

HIV-2 Genetic Evolution in Patients with Advanced Disease Is Faster than That in Matched HIV-1 Patients
Skar H, Borrego P, Wallstrom Tc, Mild M, Marcelino Jm, Barroso H, et al
JOURNAL OF VIROLOGY 2010;84(14):7412-5

Increased sensitivity to neutralizing antibodies of end-stage disease R5 HIV-1 is concomitant with reduced gp120 glycosylation and increased plus charge
Fenyo E, Borggren M, Repits J, Sterjovski J, Uchtenhagen H, Karlsson A, et al
AIDS RESEARCH AND HUMAN RETROVIRUSES 2010;26(10):A55-A55

Low Prevalence of Transmitted Drug Resistance Among Newly Diagnosed HIV-1 Patients in Latvia
Balode D, Westman M, Kolupajeva T, Rozentale B, Albert J
JOURNAL OF MEDICAL VIROLOGY 2010;82(12):2013-8

Microbial Translocation Correlates with the Severity of Both HIV-1 and HIV-2 Infections
Nowroozalizadeh S, Mansson F, Da Silva Z, Repits J, Dabo B, Pereira C, et al
JOURNAL OF INFECTIOUS DISEASES 2010;201(8):1150-4

Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment
Murillo W, De Rivera Il, Parham L, Jovel E, Palou E, Karlsson Ac, et al
HIV MEDICINE 2010;11(2):95-103

Towards an understanding of the migration of Crimean-Congo hemorrhagic fever virus
Mild M, Simon M, Albert J, Mirazimi A
JOURNAL OF GENERAL VIROLOGY 2010;:199-207

Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras
Murillo W, Paz-bailey G, Morales S, Monterroso E, Paredes M, Dobbs T, et al
JOURNAL OF CLINICAL VIROLOGY 2010;49(4):239-44

Analysis of HIV DNA molecules in single infected cells from recently and chronically infected patients
Palmer S, Josefsson L, Brannstrom J, Maldarelli F, Kearney M, Shao W, et al
ANTIVIRAL THERAPY 2009;14(4):A99-A99

Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections
Nowroozalizadeh S, Mansson F, Da Silva Z, Repits J, Dabo B, Pereira C, et al
CYTOKINE 2009;46(3):325-31

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
Spread Programme, Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing Amj, et al
RETROVIROLOGY 2009;:49-

Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe
Spread Programme, Vercauteren J, Wensing Amj, Van De Vijver Damc, Albert J, Balotta C, et al
JOURNAL OF INFECTIOUS DISEASES 2009;200(10):1503-8

Treatment of HIV infection: Swedish recommendations 2009
Josephson F, Albert J, Flamholc L, Gisslen M, Karlstrom O, Moberg L, et al
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES 2009;41(11-12):788-807

Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-I variants emerging during AIDS progression
Borggren M, Repits J, Kuylenstierna C, Sterjovski J, Churchill Mj, Purcell Dfj, et al
RETROVIROLOGY 2008;:28-

Multiple HIV-1 introductions into the Swedish intravenous drug user population
Skar H, Sylvan S, Hansson Hb, Gustavsson O, Boman H, Albert J, et al
INFECTION GENETICS AND EVOLUTION 2008;8(5):545-52

Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge
Repits J, Sterjovski J, Badia-martinez D, Mild M, Gray L, Churchill Mj, et al
VIROLOGY 2008;379(1):125-34

Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2007
Naver L, Bohlin Ab, Albert J, Flamholc L, Gisslen M, Gyllensten K, et al
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES 2008;40(6-7):451-61

Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: Results from an international collaboration on HIV-2 infection in 2006
Achiev2e Collaboration Hiv 2 Infe, Damond F, Benard A, Ruelle J, Alabi A, Kupfer B, et al
JOURNAL OF CLINICAL MICROBIOLOGY 2008;46(6):2088-91

Transmission of drug-resistant HIV-1 in Europe remains limited to single classes
Spread Programme, Wensing Amj, Vercauteren J, Van De Vijver Da, Albert J, Asjo B, et al
AIDS 2008;22(5):625-35

Antiretroviral treatment of HIV infection: Swedish recommendations 2007
Josephson F, Albert J, Flamholc L, Gisslen M, Karlstrom O, Lindgren Sr, et al
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES 2007;39(6-7):486-507

Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene
Jallow S, Kaye S, Schutten M, Brandin E, Albert J, Mcconkey Sj, et al
JOURNAL OF CLINICAL MICROBIOLOGY 2007;45(5):1565-71

Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma
Abdel-hamid M, El-daly M, Molnegren V, El-kafrawy S, Abdel-latif S, Esmat G, et al
JOURNAL OF GENERAL VIROLOGY 2007;:1526-31

Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines
Albert J, Chiodi F, Fenyo Em
JOURNAL OF INTERNAL MEDICINE 2007;262(1):2-4

Antiretroviral therapy does not induce HIV type 1-specific neutralizing activity against autologous HIV type 1 isolates
Devito C, Hejdeman B, Albert J, Broliden K, Hinkula J
AIDS RESEARCH AND HUMAN RETROVIRUSES 2006;22(9):908-11

Antiretroviral treatment of HIV infection: Swedish recommendations 2005
Swedish Consensus Grp, Gisslen M, Ahlqvist-rastad J, Albert J, Blaxhult A, Hamberg Ak, et al
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES 2006;38(2):86-103

Compensatory fixation explains long term persistence of the M41L in HIV-1 reverse transcriptase in a large transmission cluster
Huigen Mcdg, Albert J, Lindstrom A, Ohlis A, Bratt G, De Graaf L, et al
ANTIVIRAL THERAPY 2006;11(5):S113-S113

HIV-1 transmission cluster with M41L 'singleton' mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual men
Lindstrom A, Ohlis A, Huigen M, Nijhuis M, Berglund T, Bratt G, et al
ANTIVIRAL THERAPY 2006;11(8):1031-9

Rapid viral decay in simian immunodeficiency virus-infected macaques receiving quadruple antiretroviral therapy
Brandin E, Thorstensson R, Bonhoeffer S, Albert J
JOURNAL OF VIROLOGY 2006;80(19):9861-4

Transmission of drug-resistance in Europe is characterized by single mutations and revertants
Spread-program, Wensing Amj, Vercauteren J, Van De Vijver Da, Albert J, Poggensee G, et al
ANTIVIRAL THERAPY 2006;11(5):S111-S111

Coreceptor usage of primary HIV type 1 isolates obtained from different lymph node subsets
Casper C, Mild M, Jansson M, Karlsson A, Holmberg V, Bratt G, et al
AIDS RESEARCH AND HUMAN RETROVIRUSES 2005;21(12):1003-10

Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue
Karlsson I, Grivel Jc, Chen Ss, Karlsson A, Albert J, Fenyo Em, et al
JOURNAL OF VIROLOGY 2005;79(17):11151-60

Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation
Shi Y, Brandin E, Vincic E, Jansson Ma, Blaxhult A, Gyllensten K, et al
JOURNAL OF GENERAL VIROLOGY 2005;:3385-96

HIV type 2 dynamics
Brandin E, Brostrom C, Gille E, Bonhoeffer S, Albert J
AIDS RESEARCH AND HUMAN RETROVIRUSES 2005;21(7):608-10

Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency
Repits J, Oberg M, Esbjornsson J, Medstrand P, Karlsson A, Albert J, et al
JOURNAL OF GENERAL VIROLOGY 2005;:2859-69

Cerebrospinal fluid viral load, virus isolation, and intrathecal immunoactivation in HIV type 2 infection
Arvidson N, Gisslen M, Albert J, Brandin E, Svennerholm B, Fuchs D, et al
AIDS RESEARCH AND HUMAN RETROVIRUSES 2004;20(7):711-5

Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype
Karlsson I, Antonsson L, Shi Y, Oberg M, Karlsson A, Albert J, et al
JOURNAL OF VIROLOGY 2004;78(21):11807-15

Pyrosequencing for detection of lamivudine-resistant hepatitis B virus
Lindstrom A, Odeberg J, Albert J
JOURNAL OF CLINICAL MICROBIOLOGY 2004;42(10):4788-95

Updated European recommendations for the clinical use of HIV drug resistance testing
Vandamme Am, Sonnerborg A, Ait-khaled M, Albert J, Asjo B, Bacheler L, et al
ANTIVIRAL THERAPY 2004;9(6):829-48

A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1
Lindstrom A, Albert J
JOURNAL OF VIROLOGICAL METHODS 2003;107(1):45-51

A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1 (vol 107, pg 45, 2003)
Lindstrom A, Albert J
JOURNAL OF VIROLOGICAL METHODS 2003;112(1-2):165-165

A systematic approach that identifies 11 new mutations as indicators of transmission of resistance
Spread Network, Van De Vijver Damc, Schuurman R, Nielsen C, Salminen M, Albert J, et al
ANTIVIRAL THERAPY 2003;8(3):U125-U126

Characterization of novel recombinant HIV-1 genomes using the branching index
Wilbe K, Salminen M, Laukkanen T, Mccutchan F, Ray Sc, Albert J, et al
VIROLOGY 2003;316(1):116-25

Comparison of serologic and genetic porB-based typing of Neisseria gonorrhoeae: Consequences for future characterization
Unemo M, Olcen P, Albert J, Fredlund H
JOURNAL OF CLINICAL MICROBIOLOGY 2003;41(9):4141-7

HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use
Karlsson I, Antonsson L, Shi Y, Karlsson A, Albert J, Leitner T, et al
AIDS 2003;17(18):2561-9

pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy
Brandin E, Lindborg L, Gyllensten K, Brostrom C, Hagberg L, Gisslen M, et al
AIDS RESEARCH AND HUMAN RETROVIRUSES 2003;19(7):543-50

A new cell line-based neutralization assay for primary HIV type 1 isolates
Shi Y, Albert J, Francis G, Holmes H, Fenyo Em
AIDS RESEARCH AND HUMAN RETROVIRUSES 2002;18(13):957-67

CCR5 or CXCR4 is required for efficient infection of peripheral blood mononuclear cells by promiscuous human immunodeficiency virus type 2 primary isolates
Morner A, Bjorndal A, Leandersson Ac, Albert J, Bjorling E, Jansson M
AIDS RESEARCH AND HUMAN RETROVIRUSES 2002;18(3):193-200

Coreceptor change appears after immune deficiency is established in children infected with different HIV-1 subtypes
Casper C, Naver L, Clevestig P, Belfrage E, Leitner T, Albert J, et al
AIDS RESEARCH AND HUMAN RETROVIRUSES 2002;18(5):343-52

Evolution of coreceptor usage of HIV-1 isolates of different genetic subtypes in pregnant women and their infected children
Casper C, Nayer L, Belfrage E, Leitner T, Albert J, Lindgren S, et al
PEDIATRIC RESEARCH 2002;51(4):266A-266A

Identification of two CRF11-cpx genomes and two preliminary representative of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon
Wilbe K, Casper C, Albert J, Leitner T
AIDS RESEARCH AND HUMAN RETROVIRUSES 2002;18(12):849-56

Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child
Casper Che, Clevestig P, Carlenor E, Leitner T, Anzen B, Lidman K, et al
JOURNAL OF INFECTIOUS DISEASES 2002;186(7):914-21

Molecular epidemiology of Neisseria gonorrhoeae: sequence analysis of the por beta gene confirms presence of two circulating strains
Unemo M, Olcen P, Berglund T, Albert J, Fredlund H
JOURNAL OF CLINICAL MICROBIOLOGY 2002;40(10):3741-9

Strategies for diagnosis of HTLV-I and -II
Thorstensson R, Albert J, Andersson S
TRANSFUSION 2002;42(6):780-91

Antigenic variation within the CD4 binding site of human immunodeficiency virus type 1 gp120: Effects on chemokine receptor utilization
Hammond Al, Lewis J, May J, Albert J, Balfe P, Mckeating Ja
JOURNAL OF VIROLOGY 2001;75(12):5593-603

Characterization of Chlamydia trachomatis omp1 genotypes among sexually transmitted disease patients in Sweden
Jurstrand M, Falk L, Fredlund H, Lindberg M, Olcen P, Andersson S, et al
JOURNAL OF CLINICAL MICROBIOLOGY 2001;39(11):3915-9

Epidemiology of HIV in Estonia
Ustina V, Zilmer K, Tammai L, Raukas M, Andersson A, Lilja E, et al
AIDS RESEARCH AND HUMAN RETROVIRUSES 2001;17(1):81-5

Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates
Jansson M, Backstrom E, Scarlatti G, Bjorndal A, Matsuda S, Rossi P, et al
AIDS RESEARCH AND HUMAN RETROVIRUSES 2001;17(15):1405-14

Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing
O'meara D, Wilbe K, Leitner T, Hejdeman B, Albert J, Lundeberg J
JOURNAL OF CLINICAL MICROBIOLOGY 2001;39(2):464-73

Quantification of HIV-1 using multiple quantitative polymerase chain reaction standards and bioluminometric detection
Nygren M, Ronaghi M, Nyren P, Albert J, Lundeberg J
ANALYTICAL BIOCHEMISTRY 2001;288(1):28-38

Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women
European Network Utero Transmissio, Tscherning-casper C, Vodros D, Menu E, Aperia K, Fredriksson R, et al
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2000;24(1):1-9

Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1
Leandersson Ac, Gilljam G, Fredriksson M, Hinkula J, Alaeus A, Lidman K, et al
JOURNAL OF VIROLOGY 2000;74(10):4888-90

Evaluation of a prototype Amplicor PCR assay for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults infected with HIV-1 subtypes A, C and D
Lyamuya E, Olausson-hansson E, Albert J, Mhalu F, Biberfeld G
JOURNAL OF CLINICAL VIROLOGY 2000;17(1):57-63

Evidence of the existence of a new circulating recombinant form of HIV type 1 subtype A/J in Cameroon
European Network Study In Utero, Tscherning-casper C, Dolcini G, Mauclere P, Fenyo Em, Barre-sinoussi F, et al
AIDS RESEARCH AND HUMAN RETROVIRUSES 2000;16(13):1313-8

High plasma levels of soluble Fas in HIV type 1-infected subjects are not normalized during highly active antiretroviral therapy
De Milito A, Hejdeman B, Albert J, Aleman S, Sonnerborg A, Zazzi M, et al
AIDS RESEARCH AND HUMAN RETROVIRUSES 2000;16(14):1379-84

Monoclonal antibodies to native HIV type 1 reverse transcriptase and their interaction with enzymes from different subtypes
Rytting As, Akerblom L, Albert J, Unge T, Bjorling E, Al-khalili L, et al
AIDS RESEARCH AND HUMAN RETROVIRUSES 2000;16(13):1281-94

Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa - Significantly, lower plasma virus set point in HIV-2 infection than in HIV-1 infection
Andersson S, Norrgren H, Da Silva Z, Biague A, Bamba S, Kwok S, et al
ARCHIVES OF INTERNAL MEDICINE 2000;160(21):3286-93

Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues
Van Vaerenbergh K, Van Laethem K, Albert J, Boucher Cab, Clotet B, Floridia M, et al
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2000;44(8):2109-17

Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay
Study Grp Heterogeneity Hiv Epidem, Heyndrickx L, Janssens W, Zekeng L, Musonda R, Anagonou S, et al
JOURNAL OF VIROLOGY 2000;74(1):363-70

An HIV type 1 subtype A outbreak among injecting drug users in Latvia
Ferdats A, Konicheva V, Dievberna I, Lilja E, Albert J
AIDS RESEARCH AND HUMAN RETROVIRUSES 1999;15(16):1487-90

Assay of plasma samples representing different HIV-1 genetic subtypes: An evaluation of new versions of the Amplicor HIV-1 monitor assay
Alaeus A, Lilja E, Herman S, Spadoro J, Wang J, Albert J
AIDS RESEARCH AND HUMAN RETROVIRUSES 1999;15(10):889-94

Characterization of subtype A HIV-1 from Africa by full genome sequencing
Carr Jk, Laukkanen T, Salminen Mo, Albert J, Alaeus A, Kim B, et al
AIDS 1999;13(14):1819-26

Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS
Jansson M, Backstrom E, Bjorndal A, Holmberg V, Rossi P, Fenyo Em, et al
JOURNAL OF HUMAN VIROLOGY 1999;2(6):325-38

Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy
Nijhuis M, Schuurman R, De Jong D, Erickson J, Gustchina E, Albert J, et al
AIDS 1999;13(17):2349-59

Long-term immunotherapy in HIV infection, combined with short-term antiretroviral treatment
Bratt G, Eriksson Le, Sandstrom E, Gilljam G, Hinkula J, Albert J, et al
INTERNATIONAL JOURNAL OF STD & AIDS 1999;10(8):514-21

Molecular characterization of human immunodeficiency virus (HIV)-1 and-2 in individuals from Guinea-Bissau with single or dual infections: Predominance of a distinct HIV-1 subtype A/G recombinant in West Africa
Andersson S, Norrgren H, Dias F, Biberfeld G, Albert J
VIROLOGY 1999;262(2):312-20

Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients
Bjorndal A, Sonnerborg A, Tscherning C, Albert J, Fenyo Em
AIDS RESEARCH AND HUMAN RETROVIRUSES 1999;15(7):647-53

Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage
Morner A, Bjorndal A, Albert J, Kewalramani Vn, Littman Dr, Inoue R, et al
JOURNAL OF VIROLOGY 1999;73(3):2343-9

Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D
Alaeus A, Lidman K, Bjorkman A, Giesecke J, Albert J
AIDS 1999;13(8):901-7

The molecular clock of HIV-1 unveiled through analysis of a known transmission history
Leitner T, Albert J
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 1999;96(19):10752-7

The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy
Tscherning-casper C, Papadogiannakis N, Anvret M, Stolpe L, Lindgren S, Bohlin Ab, et al
JOURNAL OF VIROLOGY 1999;73(11):9673-8

Virtually full-length sequences of HIV type 1 subtype J reference strains
Laukkanen T, Albert J, Liitsola K, Green Sd, Carr Jk, Leitner T, et al
AIDS RESEARCH AND HUMAN RETROVIRUSES 1999;15(3):293-7

Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels
Martin C, Albert J, Hansson P, Pehrsson Po, Link H, Sonnerborg A
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 1998;17(3):214-9

Differences in chemokine coreceptor usage between genetic subtypes of HIV-1
Tscherning C, Alaeus A, Fredriksson R, Bjorndal A, Deng Hk, Littman Dr, et al
VIROLOGY 1998;241(2):181-8

Drug susceptibility of subtypes A, B, C, D, and E human immunodeficiency virus type 1 primary isolates
Palmer S, Alaeus A, Albert J, Cox S
AIDS RESEARCH AND HUMAN RETROVIRUSES 1998;14(2):157-62

Dual effect of interleukin 4 on HIV-1 expression: Implications for viral phenotypic switch and disease progression
Valentin A, Lu Wh, Rosati M, Schneider R, Albert J, Karlsson A, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 1998;95(15):8886-91

Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants
Carr Jk, Salminen Mo, Albert J, Sanders-buell E, Gotte D, Birx Dl, et al
VIROLOGY 1998;247(1):22-31

MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals
Bratt G, Leandersson Ac, Albert J, Sandstrom E, Wahren B
AIDS 1998;12(7):729-36

Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy
Nijhuis M, Boucher Cab, Schipper P, Leitner T, Schuurman R, Albert J
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 1998;95(24):14441-6

Tempo and mode of nucleotide substitution in gag and env gene fragments in human immunodeficiency virus type 1 populations with a known transmission history (vol 71, pg 4761, 1997)
Leitner T, Kumar S, Albert J
JOURNAL OF VIROLOGY 1998;72(3):2565-2565

The effect of changing IDV to SQV+RTV in patients with viral failure
Koppel K, Bratt G, Nilsson A, Albert J, Sandstrom E
AIDS 1998;:S47-S47

Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment
Bratt G, Karlsson A, Leandersson Ac, Albert J, Wahren B, Sandstrom E
AIDS 1998;12(16):2193-202

Use of multiple competitors for quantification of human immunodeficiency virus type 1 RNA in plasma
Vener T, Nygren M, Andersson A, Uhlen M, Albert J, Lundeberg J
JOURNAL OF CLINICAL MICROBIOLOGY 1998;36(7):1864-70

CD8(+) T cells from HIV type 1-seronegative individuals suppress virus replication in acutely infected cells
Rosok B, Voltersvik P, Larsson Bm, Albert J, Brinchmann Je, Asjo B
AIDS RESEARCH AND HUMAN RETROVIRUSES 1997;13(1):79-85

Comparison of in-house and commercial sample preparation and PCR amplification systems for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults
Lyamuya E, Bredbergraden U, Albert J, Grankvist O, Msangi V, Kagoma C, et al
JOURNAL OF CLINICAL MICROBIOLOGY 1997;35(1):278-80

Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
Bjorndal A, Deng Hk, Jansson M, Fiore Jr, Colognesi C, Karlsson A, et al
JOURNAL OF VIROLOGY 1997;71(10):7478-87

Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants
Halapi E, Leitner T, Jansson M, Scarlatti G, Orlandi P, Plebani A, et al
AIDS 1997;11(14):1709-17

Differential transmission of HIV-1 and HIV-2
Christiansen Cb, Albert J, Machuca R, Nielsen C
LANCET 1997;350(9077):562-

HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau
Norrgren H, Marquina S, Leitner T, Aaby P, Melbye M, Poulsen Ag, et al
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 1997;16(1):31-8

Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic fab intrabodies against the matrix protein, p17
Levin R, Mhashilkar Am, Dorfman T, Bukovsky A, Zani G, Bagley J, et al
MOLECULAR MEDICINE 1997;3(2):96-110

Most HIV-1 genetic subtypes have entered Sweden
Alaeus A, Leitner T, Lidman K, Albert J
AIDS 1997;11(2):199-202

Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994
Krook A, Albert J, Andersson S, Biberfeld G, Blomberg J, Eklund I, et al
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 1997;15(5):381-6

Subtype-specific problems with quantification of plasma HIV-1 RNA
Alaeus A, Lidman K, Sonnerborg A, Albert J
AIDS 1997;11(7):859-65

Tempo and mode of nucleotide substitutions in gag and env gene fragments in human immunodeficiency virus type 1 populations with a known transmission history
Leitner T, Kumar S, Albert J
JOURNAL OF VIROLOGY 1997;71(6):4761-70

The influence of MT-2 tropism on the prognostic implications of the Delta 32 deletion in the CCR-5 gene
Bratt G, Sandstrom E, Albert J, Samson M, Wahren B
AIDS 1997;11(12):1415-9

Two cases of oral-to-genital HIV-1 transmission
Bratt Ga, Berglund T, Glantzberg Bl, Albert J, Sandstrom E
INTERNATIONAL JOURNAL OF STD & AIDS 1997;8(8):522-5

Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis
Leitner T, Escanilla D, Franzen C, Uhlen M, Albert J
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 1996;93(20):10864-9

Biological phenotype of HIV type 2 isolates correlates with V3 genotype
Albert J, Stalhandske P, Marquina S, Karis J, Fouchier Ram, Norrby E, et al
AIDS RESEARCH AND HUMAN RETROVIRUSES 1996;12(9):821-8

Coexistence of subtypes B, F, and a B/F env recombinant of HIV type 1 in Buenos Aires, Argentina
Marquina S, Leitner T, Rabinovich Rd, Benetucci J, Libonatti O, Albert J
AIDS RESEARCH AND HUMAN RETROVIRUSES 1996;12(17):1651-4

Interplay of HIV-1 phenotype and neutralizing antibody response in pathogenesis of AIDS
Scarlatti G, Leitner T, Hodara V, Jansson M, Karlsson A, Wahlberg J, et al
IMMUNOLOGY LETTERS 1996;51(1-2):23-8

Molecular epidemiology and MT-2 cell tropism of Russian HIV type 1 variants
Leitner T, Korovina G, Marquina S, Smolskaya T, Albert J
AIDS RESEARCH AND HUMAN RETROVIRUSES 1996;12(17):1595-603

Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype
Weber J, Fenyo Em, Beddows S, Kaleebu P, Bjorndal A, Osmanov S, et al
JOURNAL OF VIROLOGY 1996;70(11):7827-32

Quantification of HIV-1 using multiple competitors in a single-tube assay
Vener T, Axelsson M, Albert J, Uhlen M, Lundeberg J
BIOTECHNIQUES 1996;21(2):248-52

Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates
Jansson M, Popovic M, Karlsson A, Cocchi F, Rossi P, Albert J, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 1996;93(26):15382-7

SIV infection of monkey spleen cells including follicular dendritic cells in different stages of disease
Stahmer I, Ordonez C, Popovic M, Mesquita R, Ekman M, Albert J, et al
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 1996;11(1):1-9

The role of the humoral immune response in HIV infection
Fenyö Em, Albert J, Mckeating J
AIDS (London, England) 1996;10 Suppl A():S97-106

AUTOLOGOUS NEUTRALIZING ANTIBODY-RESPONSE AND VIRUS PHENOTYPE IN PROGRESSION OF DISEASE OF HIV-1-INFECTED CHILDREN
Scarlatti G, Hodara V, Colognesi C, Beretta A, Albert J, Fenyo Em
JOURNAL OF CELLULAR BIOCHEMISTRY 1995;:243-243

BIOLOGICAL AND MOLECULAR CHARACTERIZATION OF SUBTYPE-D, SUBTYPE-G, AND SUBTYPE-A/D RECOMBINANT HIV-1 TRANSMISSIONS IN SWEDEN
Leitner T, Escanilla D, Marquina S, Wahlberg J, Brostrom C, Hansson Hb, et al
VIROLOGY 1995;209(1):136-46

BIOLOGICAL PHENOTYPE OF HIV-1 AND TRANSMISSION
Albert J, Fiore J, Fenyo Em, Pedersen C, Lundgren Jd, Gerstoft J, et al
AIDS 1995;9(7):822-3

Biological phenotype of HIV-1 isolates as a marker for response to treatment and development of drug resistance
Karlsson A, Parsmyr K, Aperia K, Sandstrom E, Fenyo Em, Albert J
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 1995;:35-35

CHARACTERIZATION OF HTLV-II ISOLATED FROM SWEDISH INTRAVENOUS-DRUG-USERS (IVDUS)
Popovic M, Andersson S, Ahmed R, Albert J, Bredbergraden U, Biberfeld G
AIDS RESEARCH AND HUMAN RETROVIRUSES 1995;:S141-S141

HIV-2 SEQUENCE VARIATION IN GUINEA-BISSAU - CORRELATION TO CLINICAL OUTCOME
Albert J, Leitner T, Naucler A
JOURNAL OF CELLULAR BIOCHEMISTRY 1995;:215-215

HIV-2 SEQUENCE VARIATION IN GUINEA-BISSAU - CORRELATION TO CLINICAL OUTCOME
Albert J, Leitner T, Naucler A
JOURNAL OF CELLULAR BIOCHEMISTRY 1995;:247-247

HTLV-II INFECTED SWEDISH INTRAVENOUS-DRUG-USERS CARRY SUBTYPE-A
Andersson S, Ahmed R, Bredbergraden U, Albert J, Krook A, Kall K, et al
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 1995;10(2):266-266

HUMAN T-LYMPHOTROPIC VIRUS TYPE-II AMONG INJECTING DRUG-USERS IN STOCKHOLM 1994
Krook A, Albert J, Andersson S, Engstrand A, Julander I, Kall K, et al
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 1995;10(2):267-267

LONG-TERM PROTECTION AGAINST SIV-INDUCED DISEASE IN MACAQUES VACCINATED WITH A LIVE ATTENUATED HIV-2 VACCINE
Putkonen P, Walther L, Zhang Yj, Li Sl, Nilsson C, Albert J, et al
NATURE MEDICINE 1995;1(9):914-8

Pattern of drug resistance mutations during combination therapy with AZT and zalcitabine didanosine
Sitbon G, Albert J, Aperia K, Hurtig M, Johansson C, Moberg C, et al
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 1995;:30-30

YET ANOTHER SUBTYPE OF HIV TYPE-1
Leitner T, Alaeus A, Marquina S, Lilja E, Lidman K, Albert J
AIDS RESEARCH AND HUMAN RETROVIRUSES 1995;11(8):995-7

Visa alla publikationer